Toxicity profiling of several common RNAi-based nanomedicines: a comparative study (Q47570622)

4 February 2018

title

Toxicity profiling of several common RNAi-based nanomedicines: a comparative study (English)

1 reference

4 February 2018

1 reference

Dalit Landesman-Milo

1

1 reference

4 February 2018

Dan Peer

series ordinal

2

1 reference

4 February 2018

publication date

1 February 2014

1 reference

4 February 2018

Drug delivery and translational research

published in

1 reference

4 February 2018

volume

4

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

96-103

1 reference

4 February 2018

RNA interference in biology and disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Special delivery: targeted therapy with small RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

RNAi-based nanomedicines for targeted personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Interfering with disease: a progress report on siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

RNAi and small interfering RNAs in human disease therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Cationic lipids enhance siRNA-mediated interferon response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Cationic liposome-mediated delivery of siRNAs in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Nanomedicine based approaches for the delivery of siRNA in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Integrin-targeted nanoparticles for siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Therapeutic siRNA silencing in inflammatory monocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

The association of autophagy with polyethylenimine-induced cytotoxity in nephritic and hepatic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Altering the immune response with lipid-based nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Grand challenges in modulating the immune response with RNAi nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-013-0158-7

The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells

21 January 2018

1 reference

12 December 2020

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells

1 reference

12 December 2020

Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity

1 reference

12 December 2020

Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells

1 reference

12 December 2020

10.1007/S13346-013-0158-7

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018